NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée — plaquette(s) PVC-Aluminium de 90 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400949004461 -
CIP7
4900446 -
CIS
60453382
What the source publishes
- Holder
- DIFARMED (ESPAGNE)
- Active ingredients
- INDAPAMIDE, AMLODIPINE, BÉSILATE D'AMLODIPINE
- Form
- comprimé à libération modifiée
- Package
- plaquette(s) PVC-Aluminium de 90 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2021-03-23
- Prescription
- Prescription or restricted
Names this record is found by
- NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée — plaquette(s) PVC-Aluminium de 90 comprimé(s)
- NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée
- INDAPAMIDE
- AMLODIPINE
- BÉSILATE D'AMLODIPINE
Complete source data
{
"cis": "60453382",
"cip7": "4900446",
"form": "comprimé à libération modifiée",
"name": "NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée — plaquette(s) PVC-Aluminium de 90 comprimé(s)",
"cip13": "3400949004461",
"holder": "DIFARMED (ESPAGNE)",
"routes": [
"orale"
],
"holders": [
"DIFARMED (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "24.75",
"authorisedOn": "2021-03-23",
"compositions": [
{
"name": "INDAPAMIDE",
"nature": "SA",
"strength": "1,50 mg",
"linkageNumber": "1",
"substanceCode": "00819",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "AMLODIPINE",
"nature": "FT",
"strength": "10 mg",
"linkageNumber": "2",
"substanceCode": "39727",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "BÉSILATE D'AMLODIPINE",
"nature": "SA",
"strength": "13,87 mg",
"linkageNumber": "2",
"substanceCode": "93748",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "2.76",
"medicinePrice": "21.99",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) PVC-Aluminium de 90 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2022-05-16",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"INDAPAMIDE",
"AMLODIPINE",
"BÉSILATE D'AMLODIPINE"
],
"authorisationProcedure": "Autorisation d'importation parallèle",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400949004461"